Skip to main content
. Author manuscript; available in PMC: 2009 Nov 1.
Published in final edited form as: Mol Cancer Ther. 2008 Nov;7(11):3470–3479. doi: 10.1158/1535-7163.MCT-08-0625

Table 1.

Protection against chemical carcinogenesis by oltipraz in rodents

Carcinogen Species (sex/strain) Tumor target organ Reference

BBN Mouse (♂, BDF and C57BL/6) Bladder (27, 81)

PhIP Rat (♂, F344) Blood/Lymphoma (82)

AOM Rat (♂, F344 and Sprague-Dawley) Colon (13, 8386)

AFB1 Rat (♂, F344) Kidney (9)

AFB1 Rat (♂, F344) Liver (26, 8790)

B[a]P, DEN, UM Mouse (Mice (♀, ICR/Ha) Lung (8)
B[a]P Mouse (Mice (♀, A/J) Lung (91)
MNU, DEN Hamster (♂, Syrian) Lung (10)
BOP Hamster (Mice (♀, Syrian) Lung (92)

BOP Hamster (Mice (♀, Syrian) Pancreas (93)

DEN Hamster (♂, Syrian) Trachea (94)

MNNG Rat (♂, Wistar) Glandular stomach (95)
B[a]P Mice (♀, ICR) Forestomach (96)

AFB1, aflatoxin B1; AOM, azoxymethane; BBN, N-butyl-N-(4-hydroxybutyl) nitrosamine; B[a]P, benzo[a]pyrene; BOP, N-nitrosobis(2-oxopropyl) amine; DEN, diethylnitrosamine; MNNG, N-methyl-N′-nitro-N-nitrosoguanidine; MNU, N-methyl-N-nitrosourea; PhIP, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine; UM, uracil mustard;